|
HY-100554-10mg
|
MedChemexpress LLC
|
BMY 7378 [CAS 21102-95-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-109059-1mg
|
MedChemexpress LLC
|
Fulacimstat [CAS 1488354-15-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-109059-10mg
|
MedChemexpress LLC
|
Fulacimstat [CAS 1488354-15-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-109059-100mg
|
MedChemexpress LLC
|
Fulacimstat [CAS 1488354-15-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-109059-25mg
|
MedChemexpress LLC
|
Fulacimstat [CAS 1488354-15-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-109059-5mg
|
MedChemexpress LLC
|
Fulacimstat [CAS 1488354-15-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-109059-50mg
|
MedChemexpress LLC
|
Fulacimstat [CAS 1488354-15-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-117507-1mg
|
MedChemexpress LLC
|
U92016A (hydrochloride) [CAS 149654-41-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-122331-100mg
|
MedChemexpress LLC
|
Norbormide [CAS 991-42-4]
|
|
|
|
|
HY-14569-10mg
|
MedChemexpress LLC
|
CDPPB [CAS 781652-57-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14569-100mg
|
MedChemexpress LLC
|
CDPPB [CAS 781652-57-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14569-5mg
|
MedChemexpress LLC
|
CDPPB [CAS 781652-57-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14569-50mg
|
MedChemexpress LLC
|
CDPPB [CAS 781652-57-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-15996-10mg
|
MedChemexpress LLC
|
Seviteronel [CAS 1610537-15-9]
|
|
Cancer-programmed cell death
|
|
|
HY-15996-100mg
|
MedChemexpress LLC
|
Seviteronel [CAS 1610537-15-9]
|
|
Cancer-programmed cell death
|
|
|
HY-15996-5mg
|
MedChemexpress LLC
|
Seviteronel [CAS 1610537-15-9]
|
|
Cancer-programmed cell death
|
|
|
HY-15996-50mg
|
MedChemexpress LLC
|
Seviteronel [CAS 1610537-15-9]
|
|
Cancer-programmed cell death
|
|
|
HY-17372-100mg
|
MedChemexpress LLC
|
Rofecoxib [CAS 162011-90-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-17372S-500ug
|
MedChemexpress LLC
|
Rofecoxib-d5 [CAS 544684-93-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-19436-1mg
|
MedChemexpress LLC
|
Solabegron [CAS 252920-94-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-19436-10mg
|
MedChemexpress LLC
|
Solabegron [CAS 252920-94-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-19436-25mg
|
MedChemexpress LLC
|
Solabegron [CAS 252920-94-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-19436-5mg
|
MedChemexpress LLC
|
Solabegron [CAS 252920-94-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-B0528A-1g
|
MedChemexpress LLC
|
Octopamine (hydrochloride) [CAS 770-05-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0528A-5g
|
MedChemexpress LLC
|
Octopamine (hydrochloride) [CAS 770-05-8]
|
|
Neuroscience-Neuromodulation
|
|
